FR
FACTSET RESEARCH SYSTEMS INC (FDS)·Q3 2025 Earnings Summary
Executive Summary
- Revenue beat, EPS slight miss; guidance reaffirmed. Q3 revenue was $585.5M vs ~$580.9M consensus (beat), while adjusted EPS was $4.27 vs ~$4.30 consensus (slight miss). Management reaffirmed FY25 guidance across revenue, margins, tax rate, and EPS, highlighting a solid Q4 pipeline and momentum in enterprise solutions and wealth . Consensus values retrieved from S&P Global.*
- Mixed margin picture as investment ramps. GAAP operating margin fell 350 bps YoY to 33.2% and adjusted margin declined 270 bps to 36.8%, driven by lapping a lower bonus accrual and a one-time payroll tax benefit last year, plus higher technology spend and acquisition-related costs .
- KPIs improved: organic ASV accelerated and free cash flow rose. Organic ASV grew $22.6M QoQ (+4.5% YoY to $2.30B), client count rose to 8,811, and FCF increased 5% YoY to $228.6M; annual ASV retention remained >95% .
- Catalysts: revenue beat and reaffirmed guidance; accelerating organic ASV; CEO succession effective early September; dividend raised 6% and new $400M buyback authorization—supporting confidence and capital returns .
What Went Well and What Went Wrong
-
What Went Well
- Top-line outperformance and pipeline strength: revenue +5.9% YoY to $585.5M; management emphasized strong enterprise solutions momentum and visibility into Q4 deals; guidance reaffirmed .
- Wealth and data solutions traction: management cited double‑digit wealth ASV growth and improving data feeds demand, including real-time and reference data; Pitch Creator gained 10 signed deals within ~6 months of launch, with >45 opportunities .
- Cash generation and returns: FCF rose to $228.6M; dividend increased to $1.10 (26th consecutive annual raise) and new $400M buyback authorization effective Sept 1, 2025 .
-
What Went Wrong
- Margin compression continued: GAAP operating margin 33.2% (−350 bps YoY) and adjusted 36.8% (−270 bps YoY), reflecting normalized bonus accruals, higher payroll/tax compares, tech investment, and M&A amortization .
- Pricing headwind from lower CPI: Q3 annual price increase captured ~$11M, but below last year, pressuring ASV growth; similar CPI-linked pricing impact internationally .
- Buy-side headwinds and EMEA softness: asset owners remained cost-focused; EMEA buy-side pressures and lower price uplift weighed on results (though management expects Q4 improvement) .
Financial Results
- Consensus values retrieved from S&P Global.*
Segment/Geographic revenue
KPIs and operating metrics
Non-GAAP adjustments (Q3 2025)
- Adjusted EPS excludes ~$0.36/share intangible amortization and ~$0.04/share acquisition-related costs .
Guidance Changes
Earnings Call Themes & Trends
Management Commentary
- “We are pleased with our third quarter performance, which reflects the execution of our enterprise solution strategy… well‑positioned to finish the fiscal year with strength.” — Phil Snow, CEO .
- “The second half in fiscal 2025 is showing improved results… organic ASV growth accelerating as we meet client demands… we are reaffirming our fiscal 2025 guidance.” — Helen Shan, CFO .
- On investment cadence: “We anticipate Q4 to be the highest quarter for expense this fiscal year, with investments concentrated on our GenAI and infrastructure projects alongside go‑to‑market initiatives.” — CFO .
- On macro and growth drivers: “We’re significantly ahead of where we were… strength is really coming from enterprise solutions… the buy‑side looks really strong for Q4.” — CEO .
Q&A Highlights
- Macro vs execution: Management sees little macro change; momentum attributed primarily to product execution (data solutions, GenAI) and a more positive client tone; buy-side expected to drive Q4 .
- Q4 setup and pipeline: Booked ASV/commitments ahead of prior years; improved retention and diverse pipeline reduce reliance on any single large deal .
- Margins and investments: To land within 36–37% adjusted operating margin for FY; Q4 expenses step up for GenAI, infra, and acquisitions integration .
- EMEA outlook: Despite Q3 softness and lower price uplift, management expects Q4 reacceleration driven by pipeline breadth; annual price headwind normalizes YoY compare .
- GenAI commercialization: 10 Pitch Creator deals signed; strong traction for conversational API; early contribution from portfolio commentary; pricing framed as subscription plus usage to ensure cost visibility for clients .
Estimates Context
- Q3 2025: Revenue beat; EPS slight miss. Revenue $585.5M vs ~$580.9M consensus; adjusted EPS $4.27 vs ~$4.30 consensus . Consensus values retrieved from S&P Global.*
- Trajectory vs prior quarters: Q1 and Q2 each modestly exceeded revenue consensus; EPS outperformed in Q1/Q2, then slightly missed in Q3 . Consensus values retrieved from S&P Global.*
Consensus vs actuals (recent quarters)
- Values retrieved from S&P Global.*
Key Takeaways for Investors
- Revenue resilience with improving momentum: Q3 revenue beat and accelerating organic ASV support confidence into seasonally strong Q4; buy‑side enterprise solutions and wealth remain core growth engines .
- Investment phase weighing on margins tactically: Margin compression reflects normalization of bonus accruals, tech spend, and M&A amortization; management remains committed to 36–37% adjusted margin for FY25 .
- AI monetization is real and broadening: Early but tangible revenue from GenAI (Pitch Creator, conversational API, portfolio commentary) with >45 active opportunities; expect incremental Q4 contribution .
- Pricing normalization is a manageable headwind: Lower CPI reduces annual uplift, but offset by volume, rate card adjustments, and enterprise wins; watch EMEA reacceleration in Q4 .
- Capital returns signal confidence: Dividend raised 6% and new $400M buyback authorization add support to the equity story alongside sustained FCF generation .
- CEO transition viewed as constructive: Incoming CEO with deep financial/tech pedigree (JPMorgan) aligns with enterprise strategy and AI focus .
References:
- Q3 2025 press release and exhibits:
- Q3 2025 8‑K and press release exhibit:
- Q3 2025 earnings call transcript:
- Q2 2025 press release/8‑K/call:
- Q1 2025 press release/8‑K/call:
- Dividend and CEO succession releases:
Note: Consensus estimates marked with an asterisk (*) are values retrieved from S&P Global.